EU recommendations for 2026/2027 seasonal flu vaccine composition

Imported from official source

Announcement

Safety Classified by Officially

EMA has issued recommendations for the influenza virus strains/sequences  that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2026.

Please refer to the latest version of the document in the ‘Related documents’ section. The document specifies the additional strains/sequences and the updated annex I of the recommendation (Reagents for vaccine standardisation).

Every year, EMA issues EU recommendations for the composition of seasonal influenza vaccines on the basis of observations by the World Health Organization (WHO), which are informed by regular monitoring activities on the prevalence and characteristics of different influenza viruses worldwide.

The following is recommended for live-attenuated vaccines or egg-based vaccines for the 2026/2027 season:

  • an A/Missouri/11/2025 (H1N1)pdm09-like virus;
  • an A/Darwin/1454/2025 (H3N2)-like virus;
  • a B/Tokyo/EIS13-175/2025 (B/Victoria lineage)-like virus. 
  • The following is recommended for cell-based or nucleic acid-based vaccines for the 2026/2027 season:

  • an A/Missouri/11/2025 (H1N1)pdm09-like virus;
  • an A/Darwin/1415/2025 (H3N2)-like virus;
  • a B/Pennsylvania/14/2025 (B/Victoria lineage)-like virus.
  • Previously, most authorised influenza vaccines were formulated to protect against the four main strains of influenza responsible for seasonal flu, including the strain known as B/Yamagata. However, since B/Yamagata has not been detected in circulation since March 2020, it is considered to no longer pose a threat to public health. As a result, there is no EU recommendation for a B/Yamagata strain in seasonal influenza vaccines for the 2026/2027 influenza season, which is in line with the respective WHO recommendation regarding the composition of vaccines for 2026/2027.

    This is an extract. The publication continues at the source.

    Source: European Medicines Agency.

    Read the original at the source: https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-composition

    Officially imported this from European Medicines Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

    Provenance

    Organization
    European Medicines Agency — imported from official source
    Official source
    https://www.ema.europa.eu/en/news.xml RSS
    Imported
    November 17, 2026 14:00
    Versions
    1 recorded
    Identity
    https://www.ema.europa.eu/en/news/eu-recommendations-2026-2027-seasonal-flu-vaccine-com...

    Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.